Indeed, PAI-1 can serve as a marker to evaluate the metastatic risk of breast cancer, as the positive correlation of PAI-1 and mesenchymal features is well characterized in breast cancer patients. The gene discussed is SERPINE1; the disease is breast carcinoma.